Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina, the Tiara™ technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves.
Type
Public
HQ
Richmond, CA
Founded
2008
Size (employees)
205 (est)+39%
Neovasc was founded in 2008 and is headquartered in Richmond, CA

Key People at Neovasc

Alexei Marko

Alexei Marko

CEO & Director
Christopher Clark

Christopher Clark

CFO
Brian McPherson

Brian McPherson

COO

Neovasc Office Locations

Neovasc has office in Richmond
Richmond, CA

Neovasc Metrics

Neovasc Summary

Market capitalization

$91.6 M

Closing share price

$1.39
Neovasc's current market capitalization is $91.6 M.

Neovasc Market Value History

Neovasc Online Presence

Neovasc Company Life

You may also be interested in